Reco analystes EyePoint, Inc.

Actions

EYPT

US30233G2093

Produits pharmaceutiques

Temps réel estimé Cboe BZX Autres places de cotation 19:13:37 23/07/2026			Varia. 5j.	Varia. 1 janv.
12,76 ^USD	+0,79%		-2,76%	-30,60%

17/07	EyePoint Pharmaceuticals accepte un accord transactionnel suite à des allégations de violation du False Claims Act aux États-Unis	MT
16/07	EYEPOINT, INC. : Stifel Nicolaus toujours positif	ZM

Reco analystes

16/07	EYEPOINT, INC. : Stifel Nicolaus toujours positif	ZM
01/07	EYEPOINT, INC. : Chardan Research à l'achat	ZM
07/05	EYEPOINT, INC. : RBC Capital Markets toujours positif	ZM
05/03	EYEPOINT, INC. : Chardan Research favorable sur le dossier	ZM
06/11	EYEPOINT PHARMACEUTICALS, INC. : RBC Capital Markets toujours à l'achat	ZM
14/08/25	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities optimiste sur le dossier	ZM
17/06/25	EYEPOINT PHARMACEUTICALS, INC. : RBC Capital Markets passe de neutre à achat	ZM
16/05/25	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities reste à l'achat	ZM
07/01/25	EYEPOINT PHARMACEUTICALS, INC. : Citigroup revoit son opinion à la hausse	ZM
16/10/24	EYEPOINT PHARMACEUTICALS, INC. : Scotiabank favorable au dossier	ZM
04/06/24	EYEPOINT PHARMACEUTICALS, INC. : Opinion positive de JPMorgan Chase	ZM
08/05/24	EYEPOINT PHARMACEUTICALS, INC. : Baird persiste à l'achat	ZM
07/05/24	EYEPOINT PHARMACEUTICALS, INC. : Opinion positive de Chardan Research	ZM
07/05/24	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities toujours à l'achat	ZM
15/02/24	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities toujours à l'achat	ZM
22/01/24	EYEPOINT PHARMACEUTICALS, INC. : JPMorgan Chase persiste à l'achat	ZM
11/12/23	EYEPOINT PHARMACEUTICALS, INC. : Capital One Securities reste à l'achat	ZM
07/12/23	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities reste à l'achat	ZM
02/11/23	EYEPOINT PHARMACEUTICALS, INC. : HC Wainwright favorable sur le dossier	ZM
02/11/23	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities persiste à l'achat	ZM
14/06/23	EYEPOINT PHARMACEUTICALS, INC. : JonesTrading Institutional Services réajuste son opinion à la hausse	ZM
19/05/23	EYEPOINT PHARMACEUTICALS, INC. : HC Wainwright à l'achat	ZM
19/05/23	EYEPOINT PHARMACEUTICALS, INC. : Chardan Research favorable sur le dossier	ZM
11/11/22	EYEPOINT PHARMACEUTICALS, INC. : Guggenheim toujours à l'achat	ZM
04/08/22	EYEPOINT PHARMACEUTICALS, INC. : HC Wainwright toujours à l'achat	ZM